Tuesday , March 28 2023

Invention for the Lung Cancer Care at the University & # 39; Ege


As a result of & # 39; the studies in Nuclear Sciences Institute & # 39; the Ege University (EÜ) and in Drug Development Research Center and Pharmacokinetics (ARGEFAR) f & # 39; Zirmira, was developed and protected protective product for the diagnosis and treatment of lung cancer. On the prototype developed in the scope of the project TUBITAK Read. Rector Prof. Dr. Dr. İskender Ince information received by the Rector. Dr. Necdet Budak congratulated Ince.

The team & # 39; research done by teachers to work in & # 39; different disciplines of EÜ of Nuclear Sciences Institute EÜ Faculty of Medicine, Öğr. Read. Dr. TUBITAK In scope of the project carried out under the management & # 39; İskender Ince, was an important invention for the diagnosis and treatment of lung cancer. During the treatment of lung cancer, has developed a prototype product that does not harm the cells with & # 39; health and lead successfully enabling the tumor cells to be effective. The prototype developed by bijoattiva substance called timokinon, which is included in the black seed oil, was named & # 39; & # 39 ;. TQGMNP As a result of & # 39; & # 39 over two years; studies, product & # 39; TQGMNP & # 39; was patented.


EÜ Rector Dr. Necdet Budak about? Prototype? Read. Dr. Ince congratulated information. E scholars pointed performed important work of President Budak, "Ege University to work in labor Nuclear Sciences Institute group prepared a medication for cancer diagnosis and therapy. I'm an open invitation to everyone all international investors in Turkey. Ege University ticarileştirilip of this preparation as domestic economy and Rector and I pray for the acquisition of mankind. the staff of our teachers bring many discoveries to the world of science. These findings should be used to benefit the society and our country.


While stressing that the preparation developed could be used both in the diagnosis and treatment of lung cancer. Read. Dr. Thin, "We have this prototype product that does not harm the cells with & # 39; health and treat c tumor cells during treatment applied to lung cancer. For this, as it says the Rector our, we need investors, "he said.

– Izmir

Source link